KCAS Bio is excited to invite you to join us this week in San Francisco, CA during AAPS NBC where Nassouh Mourabet will be giving a presentation entitled “Spectral Unmixing Impact Comparison Across Immunophenotyping Panels and Matrices”.

Nassouh Mourabet is a Scientist III in the Flow Cytometry department at KCAS Bio located in Spring House, Pennsylvania. Nassouh helps clients drive the success of their flow cytometry projects. Nassouh particularly focuses on the development, optimization, validation, and data presentation of flow cytometry panels in the support of clinical trials.

What Will You Learn During this Presentation?

KCAS Bio will present results from a recent validation of two IP panels on the Cytek Aurora in PBMCs. We have analyzed the impact of different fixation buffers on the efficacy of reference controls over time, and we will explore how to help improve workflow standards and process efficiencies in the context of ever-increasing complexity.

Additionally, you will learn to…

• Understand the constraints around using reference controls over the long term.

• Identify new parameters to test to help build best practices for single stain controls.

Why is KCAS Bio the Best CRO to Present this Data?

KCAS Bio understands the perceived difficulties with new technologies and the difficulty customers have in finding the appropriate CRO that will work with them through those new technologies. Spectral cytometry is absolutely one of the technologies in the forefront that every nearly pharmaceutical and biotech company are looking to get into, so we wanted to take the opportunity to showcase KCAS Bio’s familiarity with and expertise using this cutting edge technology.

Often when it comes to technology like this – at the cutting edge – most of what is available for review consists of research-focused, academic-focused laboratories giving talks and presentations, but there is a lack of practicality within those conversations. When a company comes to a CRO for work, they need to know that there will be efficiency, and cost-focused decisions made to ensure their project is done right and as quickly as possible. They need experience – and they need to make sure the CRO they have chosen can make the right decisions and make troubleshooting assessments in a quick and fast-paced environment.

Who Should Attend this Presentation?

AAPS NBC is a perfect opportunity to speak to a number of those who might benefit from the use of spectral flow cytometry, but who might not yet know about the advantage of the technology.

If your team is looking to see practical examples of how spectral cytometry might be able to help with your upcoming drug development project, please visit our presentation in San Francisco this week.

Please feel free to reach out through the form below if you weren’t able to make it to AAPS, but would like to explore further.